Available Technologies | Technology Commercialization

Novel anti-cancer agents that target the epigenetic reader protein
Technology No. 2021-055

            Find out more
        
Use of sulfanegen and its analogs for prevention and treatment for neurodegenerative disorders
Technology No. 2020-331

            Find out more
        
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
Technology No. 20170362

            Find out more
        
Pharmacological agents to prevent recurrent C. diff infection (20150362)
Technology No. 20150362

            Find out more